Iron oxide nanoparticles decorated with functional peptides for a targeted siRNA delivery to glioma cells

S Chung, Y Sugimoto, J Huang… - ACS Applied Materials & …, 2022 - ACS Publications
Glioma is a deadly form of brain cancer, and the difficulty of treating glioma is exacerbated
by the chemotherapeutic resistance developed in the tumor cells over the time of treatment …

MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study

M Szylberg, P Sokal, P Śledzińska, M Bebyn… - Biomedicines, 2022 - mdpi.com
Glioblastoma is the most malignant central nervous system tumor, which represents 50% of
all glial tumors. The understanding of glioma genesis, prognostic evaluation, and treatment …

The Significance of MGMT Promoter Methylation Status in Diffuse Glioma

N Jovanović, M Lazarević, VJ Cvetković… - International Journal of …, 2022 - mdpi.com
A single-institution observational study with 43 newly diagnosed diffuse gliomas defined the
isocitrate dehydrogenase 1 and 2 (IDH1/2) gene mutation status and evaluated the …

Experimental Validation and Multi-omics Analysis Identified ARPC1A as a Novel Oncogene and Potential Therapeutic Target in Glioblastoma

J Yang, C Xue, Z He, L Ying, W Meng, M Li… - Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Actin-related protein 2/3 complex subunit 1A (ARPC1A) is implicated in several cancers due
to its critical role in regulating actin polymerization. However, the exact mechanism of …

[HTML][HTML] Do clinical outcomes in individuals with malignant gliomas differ between sexes?

M Goldberg, LS Frank, G Altawalbeh, C Negwer… - Brain and Spine, 2025 - Elsevier
Introduction Sex-related differences in the epidemiology of malignant gliomas are
acknowledged; however, information regarding their clinical characteristics and outcomes …

A Comparison of MGMT Testing by MSP and qMSP in Paired Snap-Frozen and Formalin-Fixed Paraffin-Embedded Gliomas

M Lazarević, N Jovanović, VJ Cvetković, S Tošić… - Diagnostics, 2023 - mdpi.com
Comparative analysis of the conventional methylation-specific PCR (MSP) vs. the
quantitative MSP (qMSP) assessment of the O6-methylguanine-DNA methyltransferase …

[图书][B] Multifunctional Nanoparticles for Cancer Imaging and Therapy

S Chung - 2022 - search.proquest.com
Advances in nanotechnology have offered new possibilities in cancer detection and
treatment. Through the use of multifunctional nanoparticles, researchers aim to address …

1. Đánh giá tác động của đột biển gen IDH1 và sự methyl hóa gen MGMT đến thời gian sống thêm toàn bộ trên bệnh nhân u nguyên bào thần kinh đệm

KĐ Hùng, ĐTN Dung, ĐV Hệ, ND Hoa… - Tạp chí Nghiên …, 2024 - tapchinghiencuuyhoc.vn
Tóm tắt Đột biến gen IDH1 (IDH1-m) và sự methyl hóa gen MGMT (Methyl-MGMT) là những
dấu ấn sinh học phân tử đóng vai trò quan trọng trong tiên lượng đối với bệnh nhân mắc u …

[PDF][PDF] MGMT promoter methylation in prognosis of patients with newly diagnosed IDH1 wildtype Glioblastoma

PTH Trang, DTN Dung, KD Hung, D Van He, NS Lanh - jmpas.com
The objective of this study was to analyse the prognosis values of O6-methylguanine-DNA
methyltransferase (MGMT) promoter methylation on the overall survival in patients with …

Molekularna dijagnostika glioblastoma–klinički uticaji IDH mutacija i epigenetičkog utišavanja aktivnosti MGMT gena

N Jovanović, T Mitrović - Trendovi u molekularnoj Biologiji, 2022 - imagine.imgge.bg.ac.rs
Savremeni terapijski pristupi u lečenju pacijenata obolelih od glioblastoma (GBM) oslanjaju
se na primenu alkilirajućih agenasa poput Temozolomida (“Stupp”-ov protokol) …